Orchestra BioMed Holdings, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Orchestra BioMed Holdings, Inc. (OBIO) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $19.32 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $19.32M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $41.19M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $53.57M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $43.74M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | $19.32M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $41.19M 10-Q · filed 2026-08-10 | |
| 2025-12-31 | $53.57M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $43.74M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $295.00K 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $16.86M 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $32.96M 10-Q · filed 2026-08-10 | |
| 2024-09-30 | $46.22M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $44.13M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $57.19M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $68.04M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $79.66M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $89.44M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $99.75M 10-Q · filed 2024-11-12 | $99.75M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $52.53M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $61.43M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $69.51M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $78.00K 10-Q · filed 2023-11-13 | |
| 2021-12-31 | -$19.78M 10-K · filed 2024-03-27 | |
| 2020-12-31 | -$3.56M 10-K/A · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |